32 research outputs found
Program on stimulating operational private sector use of Earth observation satellite data
There are no author-identified significant results in this report
Quasiparticle spin susceptibility in heavy-fermion superconductors : An NMR study compared with specific heat results
Quasi-particle spin susceptibility () for various heavy-fermion
(HF) superconductors are discussed on the basis of the experimental results of
electronic specific heat (), NMR Knight shift () and NMR
relaxation rate () within the framework of the Fermi liquid model for a
Kramers doublet crystal electric field (CEF) ground state.
is calculated from the enhanced Sommerfeld coefficient and
from the quasi-particle Korringa relation
via the relation of
where is the hyperfine
coupling constant, the Abogadoro's number and the Bohr magneton.
For the even-parity (spin-singlet) superconductors CeCuSi, CeCoIn
and UPdAl, the fractional decrease in the Knight shift, , below the superconducting transition temperature () is due to
the decrease of the spin susceptibility of heavy quasi-particle estimated
consistently from and . This result
allows us to conclude that the heavy quasi-particles form the spin-singlet
Cooper pairs in CeCuSi, CeCoIn and UPdAl. On the other
hand, no reduction in the Knight shift is observed in UPt and
UNiAl, nevertheless the estimated values of and
are large enough to be probed experimentally. The odd-parity
superconductivity is therefore concluded in these compounds. The NMR result
provides a convincing way to classify the HF superconductors into either even-
or odd- parity paring together with the identification for the gap structure,
as long as the system has Kramers degeneracy.Comment: 11 pages, 3 tables, 5 figures, RevTex4(LaTex2e
Serum Estradiol and 20 Site-Specific Cancers in Women: Mendelian Randomization Study.
CONTEXT: The causal role of endogenous estradiol in cancers other than breast and endometrial cancer remains unclear. OBJECTIVE: This Mendelian randomization study assessed the causal associations of endogenous 17β-estradiol (E2), the most potent estrogen, with cancer risk in women. METHODS: As primary genetic instrument, we used a genetic variant in the CYP19A1 gene that is strongly associated with serum E2 levels. Summary statistics genetic data for the association of the E2 variant with breast, endometrial, and ovarian cancer were obtained from large-scale consortia. We additionally estimated the associations of the E2 variant with any and 20 site-specific cancers in 198 825 women of European descent in UK Biobank. Odds ratios (OR) of cancer per 0.01 unit increase in log-transformed serum E2 levels in pmol/L were estimated using the Wald ratio. RESULTS: Genetic predisposition to higher serum E2 levels was associated with increased risk of estrogen receptor (ER)-positive breast cancer (OR 1.02; 95% CI, 1.01-1.03; P = 2.5 × 10-3), endometrial cancer overall (OR 1.09; 95% CI, 1.06-1.11; P = 7.3 × 10-13), and endometrial cancer of the endometrioid histology subtype (OR 1.10; 95% CI, 1.07-1.13; P = 2.1 × 10-11). There were suggestive associations with breast cancer overall (OR 1.01; 95% CI, 1.00-1.02; P = 0.02), ovarian cancer of the endometrioid subtype (OR 1.05; 95% CI, 1.01-1.10; P = 0.02), and stomach cancer (OR 1.12; 95% CI, 1.00-1.26; P = 0.05), but no significant association with other cancers. CONCLUSION: This study supports a role of E2 in the development of ER-positive breast cancer and endometrioid endometrial cancer but found no strong association with other cancers in women